| Median (Q1–Q3) | r | p value |
---|---|---|---|
Socio-demographic characteristics | Â | Â | Â |
Sleep quality (PSQI) | Â | Â | Â |
Age | 52.50 (40.25–60) | − 0.32 | 0.001 |
Marital status | Â | Â | Â |
 Married | 7 (4–15) |  | 0.006 |
 Single/divorced/widow | 13 (7–17) |  |  |
Have children | Â | Â | Â |
 No | 17 (12–17) |  | 0.04 |
 Yes | 7 (4–14) |  |  |
Medical coverage system | Â | Â | Â |
 RAmed | 12 (7–17) |  | 0.000 |
 CNOPS/CNSS | 4 (2–7) |  |  |
Living area | Â | Â | Â |
 Rural | 13.5 (7–17) |  | 0.102 |
 Urban | 11.5 (4–16) |  |  |
Educational level | Â | Â | Â |
 None | 12 (6–16) |  | 0.759 |
 Compulsory school, higher educational degrees | 12 (4.75–16.75) |  |  |
Working status | Â | Â | Â |
 Housewives/retired | 10.5 (6–16) |  | 0.001 |
 Workers | 17 (13–17) |  |  |
Socio economic status | Â | Â | Â |
 Poor | 12 (7–17) |  | 0.001 |
 Good | 4 (3–7) |  |  |
Clinical characteristics | Â | Â | Â |
Surgery | Â | Â | Â |
 Hysterectomy | 11 (6–16) |  | 0.111 |
 Oophorectomy | 15 (7–17) |  |  |
Tumor stage | Â | Â | Â |
 T1 | 7 (5–16) |  | 0.689 |
 T2 | 14.5 (4–15.75) |  |  |
 T3 | 12 (7–17) |  |  |
Time since diagnosis | Â | Â | Â |
 < 1 an | 13 (7–17) |  | 0.030 |
 ≥ 1 an | 7 (4–15) |  |  |
Antineoplastic treatment | Â | Â | Â |
 One treatment | 7 (4–15) |  | 0.299 |
 Two treatment | 8 (4–17) |  |  |
 Three treatment | 2 (2–2) |  |  |
Disease recurrence | Â | Â | Â |
 No | 12 (6–16) |  | 0.476 |
 Yes | 15 (7–17) |  |  |